Pedro de Alarcón

863 total citations
25 papers, 530 citations indexed

About

Pedro de Alarcón is a scholar working on Pathology and Forensic Medicine, Genetics and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Pedro de Alarcón has authored 25 papers receiving a total of 530 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Pathology and Forensic Medicine, 8 papers in Genetics and 6 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Pedro de Alarcón's work include Lymphoma Diagnosis and Treatment (9 papers), Acute Lymphoblastic Leukemia research (4 papers) and Hemoglobinopathies and Related Disorders (3 papers). Pedro de Alarcón is often cited by papers focused on Lymphoma Diagnosis and Treatment (9 papers), Acute Lymphoblastic Leukemia research (4 papers) and Hemoglobinopathies and Related Disorders (3 papers). Pedro de Alarcón collaborates with scholars based in United States, United Kingdom and Costa Rica. Pedro de Alarcón's co-authors include Wendy G. Mitchell, Michael E. Trigg, Barbara Hero, Dominique Plantaz, Katherine K. Matthay, Franz Blaes, Michael Pike, Vito Pistoia, Roger Giller and Scott C. Howard and has published in prestigious journals such as Journal of Clinical Oncology, Blood and International Journal of Molecular Sciences.

In The Last Decade

Pedro de Alarcón

23 papers receiving 518 citations

Peers

Countries citing papers authored by Pedro de Alarcón

Since Specialization

Citations

This map shows the geographic impact of Pedro de Alarcón's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pedro de Alarcón with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pedro de Alarcón more than expected).

Fields of papers citing papers by Pedro de Alarcón

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pedro de Alarcón. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pedro de Alarcón. The network helps show where Pedro de Alarcón may publish in the future.

Co-authorship network of co-authors of Pedro de Alarcón

This figure shows the co-authorship network connecting the top 25 collaborators of Pedro de Alarcón. A scholar is included among the top collaborators of Pedro de Alarcón based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pedro de Alarcón. Pedro de Alarcón is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Risk‐Stratified and Response‐Adapted Therapy for Pediatric Hodgkin Lymphoma in Argentina: The GATLA Experience 2025 ·Advances in Hematology ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Sergio Terrasa, (unknown), Pedro de Alarcón, Eduardo Dibar, (unknown)	0
2	Pomiferin Induces Antiproliferative and Pro-Death Effects in High-Risk Neuroblastoma Cells by Modulating Multiple Cell Death Pathways 2025 ·International Journal of Molecular Sciences ·Manu Gnanamony, Maria Thomas, (unknown), (unknown), Pedro de Alarcón	0
3	Diagnosis and Management of Opsoclonus-Myoclonus-Ataxia Syndrome in Children 2022 ·Neurology Neuroimmunology & Neuroinflammation ·Thomas Rossor, E. Ann Yeh, Yasmin Khakoo, Paola Angelini, Cheryl Hemingway, Sarosh R. Irani, Gudrun Schleiermacher, Paramala Santosh, Tim Lotze, Russell C. Dale, Kumaran Deiva, Barbara Hero, Andrea Klein, Pedro de Alarcón, Mark Gorman, Wendy G. Mitchell, Ming Lim	31
4	Neonatal Hematology 2021 ·Cambridge University Press eBooks ·Pedro de Alarcón, (unknown), Robert D. Christensen, (unknown)	2
5	An in Vitro Study on the Role of Angiogenesis in Iron Deficiency Induced Reactive Thrombocytosis 2018 ·Blood ·Pedro de Alarcón, Manu Gnanamony, Jéssica Leite Garcia	2
6	Asociación de Hemato-Oncología Pediátrica de Centro América (AHOPCA): A model for sustainable development in pediatric oncology 2013 ·Pediatric Blood & Cancer ·Ronald D. Barr, Federico Antillón‐Klussmann, (unknown), Miguel Bonilla, (unknown), Marta Navarrete, Rosa M. Nieves, Armando Peña, Valentino Conter, Pedro de Alarcón, Scott C. Howard, Raul C. Ribeiro, Carlos Rodríguez‐Galindo, Maria Grazia Valsecchi, Andrea Biondi, (unknown), Gianni Tognoni, Franco Cavalli, Giuseppe Masera	72
7	Hemolytic Disease of the Fetus and Newborn 2013 ·NeoReviews ·(unknown), Pedro de Alarcón	9
8	Use of joint commission international standards to evaluate and improve pediatric oncology nursing care in Guatemala 2012 ·Pediatric Blood & Cancer ·Sara W. Day, (unknown), (unknown), Judith A. Wilimas, (unknown), Pedro de Alarcón, Federico Antillón, Scott C. Howard	23
9	A sustainable model for pediatric oncology nursing education in low‐income countries 2011 ·Pediatric Blood & Cancer ·Sara W. Day, José García-Sánchez, Federico Antillón, Judith A. Wilimas, (unknown), (unknown), Pedro de Alarcón, Ching‐Hon Pui, Raul C. Ribeiro, Scott C. Howard	31
10	EARLY [¹⁸F]FLUORODEOXYGLUCOSE POSITRON EMISSION TOMOGRAPHY–BASED RESPONSE EVALUATION AFTER TREATMENT WITH GEMCITABINE AND VINORELBINE FOR REFRACTORY HODGKIN DISEASE: A CHILDREN’S ONCOLOGY GROUP REPORT 2010 ·Pediatric Hematology and Oncology ·Peter D. Cole, Kathleen M. McCarten, Richard A. Drachtman, Pedro de Alarcón, Lu Chen, Tanya Trippett, Cindy L. Schwartz	1
11	A phase II study of bortezomib with ifosfamide and vinorelbine in pediatric patients with refractory/recurrent Hodgkin disease (HD): A Children's Oncology Group (COG) study. 2010 ·Journal of Clinical Oncology ·(unknown), Richard A. Drachtman, (unknown), Tanya Trippett, Pedro de Alarcón, (unknown), R. Paul Guillerman, Kathleen M. McCarten, (unknown), (unknown)	4
12	AHOD0031: A Phase III Study of Dose-Intensive Therapy for Intermediate Risk Hodgkin Lymphoma: A Report From the Children's Oncology Group 2010 ·Blood ·Debra L. Friedman, Suzanne L. Wolden, Louis S. Constine, Lu Chen, Kathleen M. McCarten, Thomas J. FitzGerald, Pedro de Alarcón, Allen Chen, R. Hutchison, Peter F. Ehrlich, Nathan L. Kobrinsky, Meghan A. Higman, (unknown), (unknown), Tanya Trippett, Cindy L. Schwartz	15
13	Serum protein expression profiling in pediatric Hodgkin lymphoma: A report from the Children's Oncology Group 2008 ·Pediatric Blood & Cancer ·(unknown), Lisa H. Cazares, (unknown), Pedro de Alarcón, Gary M. Kupfer, O. John Semmes	12
14	Clinical Outcomes of Patients with Recurrent/Refractory Hodgkin Disease Receiving Cyclosporine, Interferon-γ, and Interleukin-2 Immunotherapy To Induce Autoreactivity after Autologous Stem Cell Transplantation with BEAM: A COG Study. 2007 ·Blood ·Allen Chen, R. Hutchison, Allan D. Hess, Sharon L. Gardner, Tanya Trippett, Pedro de Alarcón, (unknown), (unknown), (unknown), Louis S. Constine, Lu Chen, Cindy L. Schwartz	2
15	POG 8625: A Randomized Trial Comparing Chemotherapy With Chemoradiotherapy for Children and Adolescents With Stages I, IIA, IIIA1 Hodgkin Disease 2006 ·Journal of Pediatric Hematology/Oncology ·Faith Kung, Cindy L. Schwartz, Carolyn Ferree, Wendy B. London, Jessie L. Ternberg, Fred G. Behm, Moody D. Wharam, John M. Falletta, Pedro de Alarcón, Allen R. Chauvenet	53
16	Opsoclonus myoclonus syndrome in neuroblastoma a report from a workshop on the dancing eyes syndrome at the advances in neuroblastoma meeting in Genoa, Italy, 2004 2005 ·Cancer Letters ·Katherine K. Matthay, Franz Blaes, Barbara Hero, Dominique Plantaz, Pedro de Alarcón, Wendy G. Mitchell, Michael Pike, Vito Pistoia	102
17	ABO Hemolytic Disease of the Newborn: A Unique Constellation of Findings in Siblings and Review of Protective Mechanisms in the Fetal-Maternal System 1999 ·American Journal of Perinatology ·Peter Waldron, Pedro de Alarcón	17
18	Poor cognitive outcome of eleven children with Sanfilippo syndrome after bone marrow transplantation and successful engraftment 1995 ·Kim Klein, William Krivit, Chester B. Whitley, Christina Peters, Valerie A. Cool, (unknown), Pedro de Alarcón, Martin R. Klemperer, Lauren E. Miller, R.P. Nelson, (unknown), (unknown), J. E. Wraith, Lawrence A. Lockman, Elsa Shapiro	26
19	Pulmonary resection for fungal infection in children undergoing bone marrow transplantation 1992 ·Journal of Thoracic and Cardiovascular Surgery ·Flavian M. Lupinetti, Douglas M. Behrendt, Roger Giller, Michael E. Trigg, Pedro de Alarcón	43
20	Prostaglandin E1 Bladder Instillations to Control Severe Hemorrhagic Cystitis 1990 ·The Journal of Urology ·Michael E. Trigg, (unknown), (unknown), (unknown), Myrl Holida, Pedro de Alarcón	41

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact